About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 3,141–3,150 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 3,023 |
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS REV ESP ENFERM DIG |
1130-0108 2340-4167 |
4.000 | 2.200 | Q1 | 35/147 | ARAN EDICIONES, S A |
| 3,023 |
SAE International Journal of Vehicle Dynamics Stability and NVH SAE INT J VEH DYN ST |
2380-2162 2380-2170 |
4.000 | 2.900 | Q1 | 36/182 | SAE INT |
| 3,023 |
Strategic Change-Briefings in Entrepreneurial Finance STRATEG CHANG |
1086-1718 1099-1697 |
4.000 | 3.600 | Q1 | 41/241 | JOHN WILEY & SONS LTD |
| 3,023 |
STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION STRUCT MULTIDISCIP O |
1615-147X 1615-1488 |
4.000 | 4.400 | Q1 | 30/175 | SPRINGER |
| 3,023 |
Targeted Oncology TARGET ONCOL |
1776-2596 1776-260X |
4.000 | 4.400 | Q2 | 97/326 | SPRINGER |
| 3,023 |
Therapeutic Advances in Psychopharmacology THER ADV PSYCHOPHARM |
2045-1253 2045-1261 |
4.000 | 4.200 | Q1 | 54/288 | SAGE PUBLICATIONS LTD |
| 3,023 |
Tissue Barriers TISSUE BARRIERS |
2168-8370 2168-8370 |
4.000 | 4.900 | Q2 | 61/195 | TAYLOR & FRANCIS INC |
| 3,023 |
Toxins TOXINS |
N/A 2072-6651 |
4.000 | 4.500 | Q1 | 26/106 | MDPI |
| 3,023 |
VIROLOGICA SINICA VIROL SIN |
1674-0769 1995-820X |
4.000 | 4.100 | Q1 | Oct-42 | KEAI PUBLISHING LTD |
| 3,023 |
Virus Evolution VIRUS EVOL |
N/A 2057-1577 |
4.000 | 4.500 | Q1 | Oct-42 | OXFORD UNIV PRESS |